Alvotech ALVO
4.19 USD -0.48 (-10.28%)
At closeNov 13, 2026, 4:00 PM EST
4.19 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
4.14 Day range 4.63
3.00 52-week range 6.15
- YTD
- -18.32%
- 1 year
- -24.09%
News
marketbeat.com What Alvotech (ALVO) Said on Its Q3 Earnings Call Alvotech NASDAQ: ALVO expects its full-year revenue and adjusted earnings to land near the lower end of its guidance range, as the biosimilar maker works to increase deliveries following a…
benzinga.com Corteva Posts Downbeat Q3 Results, Joins Nvidia, Alvotech And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. futures were mixed as Corteva plunged 8% after missing earnings and sales estimates; Digi, Nvidia, quantum stocks and others also fell premarket.
benzinga.com Why Tetra Tech Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket Tetra Tech shares jumped 8.5% after beating Q4 estimates; Children's Place surged 302%, while Wheeler REIT fell 35.3% premarket.
zacks.com Alvotech (ALVO) Reports Q3 Loss, Lags Revenue Estimates Alvotech (ALVO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago.
benzinga.com Alvotech Q3 EPS $(0.23) Misses $(0.07) Estimate, Sales $111.600M Miss $119.037M Estimate Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.07) by 228.57 percent. This is a 1050 percent decrease over losses of $(0.02)…
benzinga.com Alvotech Affirms FY2026 Sales Guidance of $650.000M-$700.000M vs $651.278M Est Alvotech (NASDAQ:ALVO) affirms FY2026 sales outlook from $650.000 million-$700.000 million to $650.000 million-$700.000 million vs $651.278 million estimate.
globenewswire.com Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture…
benzinga.com Jefferies Initiates Coverage On Alvotech with Buy Rating, Announces Price Target of $9 Jefferies analyst Dennis Ding initiates coverage on Alvotech (NASDAQ:ALVO) with a Buy rating and announces Price Target of $9.